Pre-earnings options volume in Sana Biotechnology (SANA) is 2.0x normal with calls leading puts 150:1. Implied volatility suggests the market is anticipating a move near 6.3%, or 16c, after results are released. Median move over the past eight quarters is 5.7%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SANA:
- Short Report: Bears test AI ‘nuclearization’ thesis, add to Oklo shorts
- Sana Biotechnology Shows Promise with Hypoimmune Platform
- Sana Biotechnology price target raised to $12 from $9 at Morgan Stanley
- Lineage Cell Therapeutics price target lowered to $3 from $5 at Maxim
- Cowen Pounds the Table on Sana Biotechnology Stock